Titre : Purines

Purines : Questions médicales fréquentes

Termes MeSH sélectionnés :

Blood Component Transfusion

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une hyperuricémie ?

Un test sanguin mesure le taux d'acide urique pour diagnostiquer l'hyperuricémie.
Hyperuricémie Acide urique
#2

Quels tests pour la goutte ?

L'analyse du liquide synovial et des tests sanguins pour l'acide urique sont utilisés.
Goutte Analyse du liquide synovial
#3

Quels symptômes indiquent une crise de goutte ?

Douleur intense, rougeur et gonflement d'une articulation, souvent le gros orteil.
Goutte Arthrite
#4

Comment évaluer une maladie liée aux purines ?

Des tests génétiques et des analyses biochimiques peuvent être nécessaires.
Maladies métaboliques Tests génétiques
#5

Quel rôle des purines dans le diagnostic ?

Les niveaux de purines peuvent indiquer des troubles métaboliques ou des maladies rénales.
Purines Troubles métaboliques

Symptômes 5

#1

Quels sont les symptômes de l'hyperuricémie ?

Souvent asymptomatique, mais peut causer des douleurs articulaires et des calculs rénaux.
Hyperuricémie Douleur articulaire
#2

Quels signes de goutte aiguë ?

Douleur intense, rougeur, chaleur et gonflement d'une articulation, souvent nocturne.
Goutte Arthrite
#3

Comment se manifeste une crise de goutte ?

Une douleur soudaine et sévère dans une articulation, souvent accompagnée d'inflammation.
Goutte Inflammation
#4

Quels symptômes des troubles des purines ?

Fatigue, douleurs articulaires, et parfois des problèmes rénaux ou hépatiques.
Troubles métaboliques Fatigue
#5

Quels symptômes d'une maladie de Wilson ?

Accumulation de cuivre, troubles neurologiques, et symptômes hépatiques.
Maladie de Wilson Troubles neurologiques

Prévention 5

#1

Comment prévenir l'hyperuricémie ?

Adopter un régime pauvre en purines et éviter l'alcool et les boissons sucrées.
Hyperuricémie Régime alimentaire
#2

Quelles habitudes pour éviter la goutte ?

Maintenir un poids santé, rester hydraté et limiter les aliments riches en purines.
Goutte Poids santé
#3

Comment réduire le risque de calculs rénaux ?

Boire beaucoup d'eau et éviter les aliments riches en oxalates et purines.
Calculs rénaux Hydratation
#4

Quels conseils diététiques pour les purines ?

Limiter les viandes rouges, les fruits de mer et les boissons alcoolisées.
Purines Régime alimentaire
#5

Comment surveiller les niveaux d'acide urique ?

Des tests sanguins réguliers pour surveiller les niveaux d'acide urique et ajuster le régime.
Acide urique Surveillance médicale

Traitements 5

#1

Comment traiter l'hyperuricémie ?

Des médicaments comme les inhibiteurs de la xanthine oxydase et des changements alimentaires.
Hyperuricémie Inhibiteurs de la xanthine oxydase
#2

Quel traitement pour la goutte ?

Anti-inflammatoires non stéroïdiens (AINS) et colchicine pour soulager la douleur.
Goutte Anti-inflammatoires non stéroïdiens
#3

Comment prévenir les crises de goutte ?

Éviter les aliments riches en purines et maintenir une hydratation adéquate.
Goutte Prévention
#4

Quels médicaments pour les troubles des purines ?

Des médicaments spécifiques selon le trouble, comme les uricosuriques pour l'hyperuricémie.
Troubles métaboliques Uricosuriques
#5

Comment gérer les calculs rénaux liés aux purines ?

Hydratation, modifications alimentaires et parfois intervention chirurgicale.
Calculs rénaux Hydratation

Complications 5

#1

Quelles complications de la goutte ?

Arthrite chronique, dépôts de tophus et risque accru de maladies cardiovasculaires.
Goutte Arthrite chronique
#2

Quels risques liés à l'hyperuricémie ?

Peut entraîner des calculs rénaux, des maladies rénales et des problèmes cardiovasculaires.
Hyperuricémie Maladies rénales
#3

Comment l'hyperuricémie affecte-t-elle les reins ?

Peut provoquer une néphropathie urique, entraînant des lésions rénales.
Néphropathie urique Hyperuricémie
#4

Quelles complications des troubles des purines ?

Peuvent inclure des problèmes hépatiques, neurologiques et des troubles métaboliques.
Troubles métaboliques Problèmes hépatiques
#5

Quels effets à long terme de la goutte ?

Peut entraîner des dommages articulaires permanents et des complications systémiques.
Goutte Dommages articulaires

Facteurs de risque 5

#1

Quels facteurs de risque pour l'hyperuricémie ?

Obésité, consommation excessive d'alcool, régime riche en purines et antécédents familiaux.
Hyperuricémie Obésité
#2

Qui est à risque de goutte ?

Les hommes, les personnes obèses et celles ayant des antécédents familiaux de goutte.
Goutte Antécédents familiaux
#3

Quels médicaments augmentent le risque d'hyperuricémie ?

Diurétiques, aspirine à faible dose et certains médicaments immunosuppresseurs.
Hyperuricémie Diurétiques
#4

Quel rôle de l'alimentation dans les purines ?

Une alimentation riche en viandes rouges, fruits de mer et boissons sucrées augmente le risque.
Purines Régime alimentaire
#5

Comment l'âge influence-t-il l'hyperuricémie ?

Le risque d'hyperuricémie augmente avec l'âge, surtout chez les hommes après 40 ans.
Hyperuricémie Âge
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Purines : Questions médicales les plus fréquentes", "headline": "Purines : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Purines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-24", "dateModified": "2025-04-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Purines" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Composés hétérobicycliques", "url": "https://questionsmedicales.fr/mesh/D006574", "about": { "@type": "MedicalCondition", "name": "Composés hétérobicycliques", "code": { "@type": "MedicalCode", "code": "D006574", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Adénine", "alternateName": "Adenine", "url": "https://questionsmedicales.fr/mesh/D000225", "about": { "@type": "MedicalCondition", "name": "Adénine", "code": { "@type": "MedicalCode", "code": "D000225", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.138" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Amino-2 purine", "alternateName": "2-Aminopurine", "url": "https://questionsmedicales.fr/mesh/D015075", "about": { "@type": "MedicalCondition", "name": "Amino-2 purine", "code": { "@type": "MedicalCode", "code": "D015075", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.138.050" } } }, { "@type": "MedicalWebPage", "name": "Cytokinine", "alternateName": "Cytokinins", "url": "https://questionsmedicales.fr/mesh/D003583", "about": { "@type": "MedicalCondition", "name": "Cytokinine", "code": { "@type": "MedicalCode", "code": "D003583", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.138.525" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Kinétine", "alternateName": "Kinetin", "url": "https://questionsmedicales.fr/mesh/D007701", "about": { "@type": "MedicalCondition", "name": "Kinétine", "code": { "@type": "MedicalCode", "code": "D007701", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.138.525.400" } } }, { "@type": "MedicalWebPage", "name": "Zéatine", "alternateName": "Zeatin", "url": "https://questionsmedicales.fr/mesh/D015026", "about": { "@type": "MedicalCondition", "name": "Zéatine", "code": { "@type": "MedicalCode", "code": "D015026", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.138.525.700" } } } ] }, { "@type": "MedicalWebPage", "name": "Kinétine", "alternateName": "Kinetin", "url": "https://questionsmedicales.fr/mesh/D007701", "about": { "@type": "MedicalCondition", "name": "Kinétine", "code": { "@type": "MedicalCode", "code": "D007701", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.138.525.400" } } }, { "@type": "MedicalWebPage", "name": "Zéatine", "alternateName": "Zeatin", "url": "https://questionsmedicales.fr/mesh/D015026", "about": { "@type": "MedicalCondition", "name": "Zéatine", "code": { "@type": "MedicalCode", "code": "D015026", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.138.525.700" } } }, { "@type": "MedicalWebPage", "name": "Famciclovir", "alternateName": "Famciclovir", "url": "https://questionsmedicales.fr/mesh/D000077595", "about": { "@type": "MedicalCondition", "name": "Famciclovir", "code": { "@type": "MedicalCode", "code": "D000077595", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.138.703" } } }, { "@type": "MedicalWebPage", "name": "Ténofovir", "alternateName": "Tenofovir", "url": "https://questionsmedicales.fr/mesh/D000068698", "about": { "@type": "MedicalCondition", "name": "Ténofovir", "code": { "@type": "MedicalCode", "code": "D000068698", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.138.881" } } } ] }, { "@type": "MedicalWebPage", "name": "Allopurinol", "alternateName": "Allopurinol", "url": "https://questionsmedicales.fr/mesh/D000493", "about": { "@type": "MedicalCondition", "name": "Allopurinol", "code": { "@type": "MedicalCode", "code": "D000493", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.160" } } }, { "@type": "MedicalWebPage", "name": "Mercaptopurine", "alternateName": "Mercaptopurine", "url": "https://questionsmedicales.fr/mesh/D015122", "about": { "@type": "MedicalCondition", "name": "Mercaptopurine", "code": { "@type": "MedicalCode", "code": "D015122", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.570" } } }, { "@type": "MedicalWebPage", "name": "Purinones", "alternateName": "Purinones", "url": "https://questionsmedicales.fr/mesh/D011688", "about": { "@type": "MedicalCondition", "name": "Purinones", "code": { "@type": "MedicalCode", "code": "D011688", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Hypoxanthines", "alternateName": "Hypoxanthines", "url": "https://questionsmedicales.fr/mesh/D007042", "about": { "@type": "MedicalCondition", "name": "Hypoxanthines", "code": { "@type": "MedicalCode", "code": "D007042", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Guanine", "alternateName": "Guanine", "url": "https://questionsmedicales.fr/mesh/D006147", "about": { "@type": "MedicalCondition", "name": "Guanine", "code": { "@type": "MedicalCode", "code": "D006147", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Aciclovir", "alternateName": "Acyclovir", "url": "https://questionsmedicales.fr/mesh/D000212", "about": { "@type": "MedicalCondition", "name": "Aciclovir", "code": { "@type": "MedicalCode", "code": "D000212", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Ganciclovir", "alternateName": "Ganciclovir", "url": "https://questionsmedicales.fr/mesh/D015774", "about": { "@type": "MedicalCondition", "name": "Ganciclovir", "code": { "@type": "MedicalCode", "code": "D015774", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Valganciclovir", "alternateName": "Valganciclovir", "url": "https://questionsmedicales.fr/mesh/D000077562", "about": { "@type": "MedicalCondition", "name": "Valganciclovir", "code": { "@type": "MedicalCode", "code": "D000077562", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Valganciclovir", "alternateName": "Valganciclovir", "url": "https://questionsmedicales.fr/mesh/D000077562", "about": { "@type": "MedicalCondition", "name": "Valganciclovir", "code": { "@type": "MedicalCode", "code": "D000077562", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300.500" } } }, { "@type": "MedicalWebPage", "name": "Valaciclovir", "alternateName": "Valacyclovir", "url": "https://questionsmedicales.fr/mesh/D000077483", "about": { "@type": "MedicalCondition", "name": "Valaciclovir", "code": { "@type": "MedicalCode", "code": "D000077483", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.650" } } } ] }, { "@type": "MedicalWebPage", "name": "Ganciclovir", "alternateName": "Ganciclovir", "url": "https://questionsmedicales.fr/mesh/D015774", "about": { "@type": "MedicalCondition", "name": "Ganciclovir", "code": { "@type": "MedicalCode", "code": "D015774", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Valganciclovir", "alternateName": "Valganciclovir", "url": "https://questionsmedicales.fr/mesh/D000077562", "about": { "@type": "MedicalCondition", "name": "Valganciclovir", "code": { "@type": "MedicalCode", "code": "D000077562", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Valganciclovir", "alternateName": "Valganciclovir", "url": "https://questionsmedicales.fr/mesh/D000077562", "about": { "@type": "MedicalCondition", "name": "Valganciclovir", "code": { "@type": "MedicalCode", "code": "D000077562", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300.500" } } }, { "@type": "MedicalWebPage", "name": "Valaciclovir", "alternateName": "Valacyclovir", "url": "https://questionsmedicales.fr/mesh/D000077483", "about": { "@type": "MedicalCondition", "name": "Valaciclovir", "code": { "@type": "MedicalCode", "code": "D000077483", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.650" } } }, { "@type": "MedicalWebPage", "name": "8-Azaguanine", "alternateName": "Azaguanine", "url": "https://questionsmedicales.fr/mesh/D001375", "about": { "@type": "MedicalCondition", "name": "8-Azaguanine", "code": { "@type": "MedicalCode", "code": "D001375", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.300" } } } ] }, { "@type": "MedicalWebPage", "name": "Aciclovir", "alternateName": "Acyclovir", "url": "https://questionsmedicales.fr/mesh/D000212", "about": { "@type": "MedicalCondition", "name": "Aciclovir", "code": { "@type": "MedicalCode", "code": "D000212", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Ganciclovir", "alternateName": "Ganciclovir", "url": "https://questionsmedicales.fr/mesh/D015774", "about": { "@type": "MedicalCondition", "name": "Ganciclovir", "code": { "@type": "MedicalCode", "code": "D015774", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Valganciclovir", "alternateName": "Valganciclovir", "url": "https://questionsmedicales.fr/mesh/D000077562", "about": { "@type": "MedicalCondition", "name": "Valganciclovir", "code": { "@type": "MedicalCode", "code": "D000077562", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Valganciclovir", "alternateName": "Valganciclovir", "url": "https://questionsmedicales.fr/mesh/D000077562", "about": { "@type": "MedicalCondition", "name": "Valganciclovir", "code": { "@type": "MedicalCode", "code": "D000077562", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300.500" } } }, { "@type": "MedicalWebPage", "name": "Valaciclovir", "alternateName": "Valacyclovir", "url": "https://questionsmedicales.fr/mesh/D000077483", "about": { "@type": "MedicalCondition", "name": "Valaciclovir", "code": { "@type": "MedicalCode", "code": "D000077483", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.650" } } } ] }, { "@type": "MedicalWebPage", "name": "Ganciclovir", "alternateName": "Ganciclovir", "url": "https://questionsmedicales.fr/mesh/D015774", "about": { "@type": "MedicalCondition", "name": "Ganciclovir", "code": { "@type": "MedicalCode", "code": "D015774", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Valganciclovir", "alternateName": "Valganciclovir", "url": "https://questionsmedicales.fr/mesh/D000077562", "about": { "@type": "MedicalCondition", "name": "Valganciclovir", "code": { "@type": "MedicalCode", "code": "D000077562", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Valganciclovir", "alternateName": "Valganciclovir", "url": "https://questionsmedicales.fr/mesh/D000077562", "about": { "@type": "MedicalCondition", "name": "Valganciclovir", "code": { "@type": "MedicalCode", "code": "D000077562", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300.500" } } }, { "@type": "MedicalWebPage", "name": "Valaciclovir", "alternateName": "Valacyclovir", "url": "https://questionsmedicales.fr/mesh/D000077483", "about": { "@type": "MedicalCondition", "name": "Valaciclovir", "code": { "@type": "MedicalCode", "code": "D000077483", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.650" } } }, { "@type": "MedicalWebPage", "name": "8-Azaguanine", "alternateName": "Azaguanine", "url": "https://questionsmedicales.fr/mesh/D001375", "about": { "@type": "MedicalCondition", "name": "8-Azaguanine", "code": { "@type": "MedicalCode", "code": "D001375", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.300" } } }, { "@type": "MedicalWebPage", "name": "Hypoxanthine", "alternateName": "Hypoxanthine", "url": "https://questionsmedicales.fr/mesh/D019271", "about": { "@type": "MedicalCondition", "name": "Hypoxanthine", "code": { "@type": "MedicalCode", "code": "D019271", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.475" } } } ] }, { "@type": "MedicalWebPage", "name": "Guanine", "alternateName": "Guanine", "url": "https://questionsmedicales.fr/mesh/D006147", "about": { "@type": "MedicalCondition", "name": "Guanine", "code": { "@type": "MedicalCode", "code": "D006147", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Aciclovir", "alternateName": "Acyclovir", "url": "https://questionsmedicales.fr/mesh/D000212", "about": { "@type": "MedicalCondition", "name": "Aciclovir", "code": { "@type": "MedicalCode", "code": "D000212", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Ganciclovir", "alternateName": "Ganciclovir", "url": "https://questionsmedicales.fr/mesh/D015774", "about": { "@type": "MedicalCondition", "name": "Ganciclovir", "code": { "@type": "MedicalCode", "code": "D015774", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Valganciclovir", "alternateName": "Valganciclovir", "url": "https://questionsmedicales.fr/mesh/D000077562", "about": { "@type": "MedicalCondition", "name": "Valganciclovir", "code": { "@type": "MedicalCode", "code": "D000077562", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Valganciclovir", "alternateName": "Valganciclovir", "url": "https://questionsmedicales.fr/mesh/D000077562", "about": { "@type": "MedicalCondition", "name": "Valganciclovir", "code": { "@type": "MedicalCode", "code": "D000077562", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300.500" } } }, { "@type": "MedicalWebPage", "name": "Valaciclovir", "alternateName": "Valacyclovir", "url": "https://questionsmedicales.fr/mesh/D000077483", "about": { "@type": "MedicalCondition", "name": "Valaciclovir", "code": { "@type": "MedicalCode", "code": "D000077483", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.650" } } } ] }, { "@type": "MedicalWebPage", "name": "Ganciclovir", "alternateName": "Ganciclovir", "url": "https://questionsmedicales.fr/mesh/D015774", "about": { "@type": "MedicalCondition", "name": "Ganciclovir", "code": { "@type": "MedicalCode", "code": "D015774", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Valganciclovir", "alternateName": "Valganciclovir", "url": "https://questionsmedicales.fr/mesh/D000077562", "about": { "@type": "MedicalCondition", "name": "Valganciclovir", "code": { "@type": "MedicalCode", "code": "D000077562", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Valganciclovir", "alternateName": "Valganciclovir", "url": "https://questionsmedicales.fr/mesh/D000077562", "about": { "@type": "MedicalCondition", "name": "Valganciclovir", "code": { "@type": "MedicalCode", "code": "D000077562", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300.500" } } }, { "@type": "MedicalWebPage", "name": "Valaciclovir", "alternateName": "Valacyclovir", "url": "https://questionsmedicales.fr/mesh/D000077483", "about": { "@type": "MedicalCondition", "name": "Valaciclovir", "code": { "@type": "MedicalCode", "code": "D000077483", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.650" } } }, { "@type": "MedicalWebPage", "name": "8-Azaguanine", "alternateName": "Azaguanine", "url": "https://questionsmedicales.fr/mesh/D001375", "about": { "@type": "MedicalCondition", "name": "8-Azaguanine", "code": { "@type": "MedicalCode", "code": "D001375", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.300" } } } ] }, { "@type": "MedicalWebPage", "name": "Aciclovir", "alternateName": "Acyclovir", "url": "https://questionsmedicales.fr/mesh/D000212", "about": { "@type": "MedicalCondition", "name": "Aciclovir", "code": { "@type": "MedicalCode", "code": "D000212", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Ganciclovir", "alternateName": "Ganciclovir", "url": "https://questionsmedicales.fr/mesh/D015774", "about": { "@type": "MedicalCondition", "name": "Ganciclovir", "code": { "@type": "MedicalCode", "code": "D015774", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Valganciclovir", "alternateName": "Valganciclovir", "url": "https://questionsmedicales.fr/mesh/D000077562", "about": { "@type": "MedicalCondition", "name": "Valganciclovir", "code": { "@type": "MedicalCode", "code": "D000077562", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Valganciclovir", "alternateName": "Valganciclovir", "url": "https://questionsmedicales.fr/mesh/D000077562", "about": { "@type": "MedicalCondition", "name": "Valganciclovir", "code": { "@type": "MedicalCode", "code": "D000077562", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300.500" } } }, { "@type": "MedicalWebPage", "name": "Valaciclovir", "alternateName": "Valacyclovir", "url": "https://questionsmedicales.fr/mesh/D000077483", "about": { "@type": "MedicalCondition", "name": "Valaciclovir", "code": { "@type": "MedicalCode", "code": "D000077483", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.650" } } } ] }, { "@type": "MedicalWebPage", "name": "Ganciclovir", "alternateName": "Ganciclovir", "url": "https://questionsmedicales.fr/mesh/D015774", "about": { "@type": "MedicalCondition", "name": "Ganciclovir", "code": { "@type": "MedicalCode", "code": "D015774", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Valganciclovir", "alternateName": "Valganciclovir", "url": "https://questionsmedicales.fr/mesh/D000077562", "about": { "@type": "MedicalCondition", "name": "Valganciclovir", "code": { "@type": "MedicalCode", "code": "D000077562", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Valganciclovir", "alternateName": "Valganciclovir", "url": "https://questionsmedicales.fr/mesh/D000077562", "about": { "@type": "MedicalCondition", "name": "Valganciclovir", "code": { "@type": "MedicalCode", "code": "D000077562", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.300.500" } } }, { "@type": "MedicalWebPage", "name": "Valaciclovir", "alternateName": "Valacyclovir", "url": "https://questionsmedicales.fr/mesh/D000077483", "about": { "@type": "MedicalCondition", "name": "Valaciclovir", "code": { "@type": "MedicalCode", "code": "D000077483", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.250.650" } } }, { "@type": "MedicalWebPage", "name": "8-Azaguanine", "alternateName": "Azaguanine", "url": "https://questionsmedicales.fr/mesh/D001375", "about": { "@type": "MedicalCondition", "name": "8-Azaguanine", "code": { "@type": "MedicalCode", "code": "D001375", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.454.300" } } }, { "@type": "MedicalWebPage", "name": "Hypoxanthine", "alternateName": "Hypoxanthine", "url": "https://questionsmedicales.fr/mesh/D019271", "about": { "@type": "MedicalCondition", "name": "Hypoxanthine", "code": { "@type": "MedicalCode", "code": "D019271", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.399.475" } } }, { "@type": "MedicalWebPage", "name": "Xanthines", "alternateName": "Xanthines", "url": "https://questionsmedicales.fr/mesh/D014970", "about": { "@type": "MedicalCondition", "name": "Xanthines", "code": { "@type": "MedicalCode", "code": "D014970", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Caféine", "alternateName": "Caffeine", "url": "https://questionsmedicales.fr/mesh/D002110", "about": { "@type": "MedicalCondition", "name": "Caféine", "code": { "@type": "MedicalCode", "code": "D002110", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.175" } } }, { "@type": "MedicalWebPage", "name": "Théobromine", "alternateName": "Theobromine", "url": "https://questionsmedicales.fr/mesh/D013805", "about": { "@type": "MedicalCondition", "name": "Théobromine", "code": { "@type": "MedicalCode", "code": "D013805", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.651" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Pentoxifylline", "alternateName": "Pentoxifylline", "url": "https://questionsmedicales.fr/mesh/D010431", "about": { "@type": "MedicalCondition", "name": "Pentoxifylline", "code": { "@type": "MedicalCode", "code": "D010431", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.651.700" } } } ] }, { "@type": "MedicalWebPage", "name": "Pentoxifylline", "alternateName": "Pentoxifylline", "url": "https://questionsmedicales.fr/mesh/D010431", "about": { "@type": "MedicalCondition", "name": "Pentoxifylline", "code": { "@type": "MedicalCode", "code": "D010431", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.651.700" } } }, { "@type": "MedicalWebPage", "name": "Théophylline", "alternateName": "Theophylline", "url": "https://questionsmedicales.fr/mesh/D013806", "about": { "@type": "MedicalCondition", "name": "Théophylline", "code": { "@type": "MedicalCode", "code": "D013806", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.751" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Diphylline", "alternateName": "Dyphylline", "url": "https://questionsmedicales.fr/mesh/D004400", "about": { "@type": "MedicalCondition", "name": "Diphylline", "code": { "@type": "MedicalCode", "code": "D004400", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.751.250" } } }, { "@type": "MedicalWebPage", "name": "Xanthine(isobutyl-3 methyl-1)", "alternateName": "1-Methyl-3-isobutylxanthine", "url": "https://questionsmedicales.fr/mesh/D015056", "about": { "@type": "MedicalCondition", "name": "Xanthine(isobutyl-3 methyl-1)", "code": { "@type": "MedicalCode", "code": "D015056", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.751.500" } } }, { "@type": "MedicalWebPage", "name": "Nicotinate de xanthinol", "alternateName": "Xanthinol Niacinate", "url": "https://questionsmedicales.fr/mesh/D014971", "about": { "@type": "MedicalCondition", "name": "Nicotinate de xanthinol", "code": { "@type": "MedicalCode", "code": "D014971", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.751.950" } } } ] }, { "@type": "MedicalWebPage", "name": "Diphylline", "alternateName": "Dyphylline", "url": "https://questionsmedicales.fr/mesh/D004400", "about": { "@type": "MedicalCondition", "name": "Diphylline", "code": { "@type": "MedicalCode", "code": "D004400", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.751.250" } } }, { "@type": "MedicalWebPage", "name": "Xanthine(isobutyl-3 methyl-1)", "alternateName": "1-Methyl-3-isobutylxanthine", "url": "https://questionsmedicales.fr/mesh/D015056", "about": { "@type": "MedicalCondition", "name": "Xanthine(isobutyl-3 methyl-1)", "code": { "@type": "MedicalCode", "code": "D015056", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.751.500" } } }, { "@type": "MedicalWebPage", "name": "Nicotinate de xanthinol", "alternateName": "Xanthinol Niacinate", "url": "https://questionsmedicales.fr/mesh/D014971", "about": { "@type": "MedicalCondition", "name": "Nicotinate de xanthinol", "code": { "@type": "MedicalCode", "code": "D014971", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.751.950" } } }, { "@type": "MedicalWebPage", "name": "Acide urique", "alternateName": "Uric Acid", "url": "https://questionsmedicales.fr/mesh/D014527", "about": { "@type": "MedicalCondition", "name": "Acide urique", "code": { "@type": "MedicalCode", "code": "D014527", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.877" } } }, { "@type": "MedicalWebPage", "name": "Xanthine", "alternateName": "Xanthine", "url": "https://questionsmedicales.fr/mesh/D019820", "about": { "@type": "MedicalCondition", "name": "Xanthine", "code": { "@type": "MedicalCode", "code": "D019820", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.938" } } } ] }, { "@type": "MedicalWebPage", "name": "Caféine", "alternateName": "Caffeine", "url": "https://questionsmedicales.fr/mesh/D002110", "about": { "@type": "MedicalCondition", "name": "Caféine", "code": { "@type": "MedicalCode", "code": "D002110", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.175" } } }, { "@type": "MedicalWebPage", "name": "Théobromine", "alternateName": "Theobromine", "url": "https://questionsmedicales.fr/mesh/D013805", "about": { "@type": "MedicalCondition", "name": "Théobromine", "code": { "@type": "MedicalCode", "code": "D013805", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.651" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Pentoxifylline", "alternateName": "Pentoxifylline", "url": "https://questionsmedicales.fr/mesh/D010431", "about": { "@type": "MedicalCondition", "name": "Pentoxifylline", "code": { "@type": "MedicalCode", "code": "D010431", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.651.700" } } } ] }, { "@type": "MedicalWebPage", "name": "Pentoxifylline", "alternateName": "Pentoxifylline", "url": "https://questionsmedicales.fr/mesh/D010431", "about": { "@type": "MedicalCondition", "name": "Pentoxifylline", "code": { "@type": "MedicalCode", "code": "D010431", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.651.700" } } }, { "@type": "MedicalWebPage", "name": "Théophylline", "alternateName": "Theophylline", "url": "https://questionsmedicales.fr/mesh/D013806", "about": { "@type": "MedicalCondition", "name": "Théophylline", "code": { "@type": "MedicalCode", "code": "D013806", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.751" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Diphylline", "alternateName": "Dyphylline", "url": "https://questionsmedicales.fr/mesh/D004400", "about": { "@type": "MedicalCondition", "name": "Diphylline", "code": { "@type": "MedicalCode", "code": "D004400", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.751.250" } } }, { "@type": "MedicalWebPage", "name": "Xanthine(isobutyl-3 methyl-1)", "alternateName": "1-Methyl-3-isobutylxanthine", "url": "https://questionsmedicales.fr/mesh/D015056", "about": { "@type": "MedicalCondition", "name": "Xanthine(isobutyl-3 methyl-1)", "code": { "@type": "MedicalCode", "code": "D015056", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.751.500" } } }, { "@type": "MedicalWebPage", "name": "Nicotinate de xanthinol", "alternateName": "Xanthinol Niacinate", "url": "https://questionsmedicales.fr/mesh/D014971", "about": { "@type": "MedicalCondition", "name": "Nicotinate de xanthinol", "code": { "@type": "MedicalCode", "code": "D014971", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.751.950" } } } ] }, { "@type": "MedicalWebPage", "name": "Diphylline", "alternateName": "Dyphylline", "url": "https://questionsmedicales.fr/mesh/D004400", "about": { "@type": "MedicalCondition", "name": "Diphylline", "code": { "@type": "MedicalCode", "code": "D004400", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.751.250" } } }, { "@type": "MedicalWebPage", "name": "Xanthine(isobutyl-3 methyl-1)", "alternateName": "1-Methyl-3-isobutylxanthine", "url": "https://questionsmedicales.fr/mesh/D015056", "about": { "@type": "MedicalCondition", "name": "Xanthine(isobutyl-3 methyl-1)", "code": { "@type": "MedicalCode", "code": "D015056", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.751.500" } } }, { "@type": "MedicalWebPage", "name": "Nicotinate de xanthinol", "alternateName": "Xanthinol Niacinate", "url": "https://questionsmedicales.fr/mesh/D014971", "about": { "@type": "MedicalCondition", "name": "Nicotinate de xanthinol", "code": { "@type": "MedicalCode", "code": "D014971", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.751.950" } } }, { "@type": "MedicalWebPage", "name": "Acide urique", "alternateName": "Uric Acid", "url": "https://questionsmedicales.fr/mesh/D014527", "about": { "@type": "MedicalCondition", "name": "Acide urique", "code": { "@type": "MedicalCode", "code": "D014527", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.877" } } }, { "@type": "MedicalWebPage", "name": "Xanthine", "alternateName": "Xanthine", "url": "https://questionsmedicales.fr/mesh/D019820", "about": { "@type": "MedicalCondition", "name": "Xanthine", "code": { "@type": "MedicalCode", "code": "D019820", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.758.824.938" } } } ] }, { "@type": "MedicalWebPage", "name": "Roscovitine", "alternateName": "Roscovitine", "url": "https://questionsmedicales.fr/mesh/D000077546", "about": { "@type": "MedicalCondition", "name": "Roscovitine", "code": { "@type": "MedicalCode", "code": "D000077546", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.776" } } }, { "@type": "MedicalWebPage", "name": "Citrate de sildénafil", "alternateName": "Sildenafil Citrate", "url": "https://questionsmedicales.fr/mesh/D000068677", "about": { "@type": "MedicalCondition", "name": "Citrate de sildénafil", "code": { "@type": "MedicalCode", "code": "D000068677", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.824" } } }, { "@type": "MedicalWebPage", "name": "Tioguanine", "alternateName": "Thioguanine", "url": "https://questionsmedicales.fr/mesh/D013866", "about": { "@type": "MedicalCondition", "name": "Tioguanine", "code": { "@type": "MedicalCode", "code": "D013866", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759.854" } } } ], "about": { "@type": "MedicalCondition", "name": "Purines", "alternateName": "Purines", "code": { "@type": "MedicalCode", "code": "D011687", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Bertrand Daignan-Fornier", "url": "https://questionsmedicales.fr/author/Bertrand%20Daignan-Fornier", "affiliation": { "@type": "Organization", "name": "Institut de Biochimie et Génétique Cellulaires, CNRS, UMR 5095, Université de Bordeaux, F-33000 Bordeaux, France." } }, { "@type": "Person", "name": "Benoît Pinson", "url": "https://questionsmedicales.fr/author/Beno%C3%AEt%20Pinson", "affiliation": { "@type": "Organization", "name": "Institut de Biochimie et Génétique Cellulaires, CNRS, UMR 5095, Université de Bordeaux, F-33000 Bordeaux, France." } }, { "@type": "Person", "name": "M Zaeem Cader", "url": "https://questionsmedicales.fr/author/M%20Zaeem%20Cader", "affiliation": { "@type": "Organization", "name": "Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK." } }, { "@type": "Person", "name": "Rodrigo Pereira de Almeida Rodrigues", "url": "https://questionsmedicales.fr/author/Rodrigo%20Pereira%20de%20Almeida%20Rodrigues", "affiliation": { "@type": "Organization", "name": "Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK." } }, { "@type": "Person", "name": "James A West", "url": "https://questionsmedicales.fr/author/James%20A%20West", "affiliation": { "@type": "Organization", "name": "Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK; Department of Biochemistry and Cambridge Systems Biology Centre, University of Cambridge, Cambridge CB2 1GA, UK." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "How do I/we forecast tomorrows' transfusion: Blood components.", "datePublished": "2022-07-30", "url": "https://questionsmedicales.fr/article/35914702", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.tracli.2022.07.006" } }, { "@type": "ScholarlyArticle", "name": "Balanced blood component resuscitation in trauma: Does it matter equally at different transfusion volumes?", "datePublished": "2022-12-15", "url": "https://questionsmedicales.fr/article/36528406", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.surg.2022.11.010" } }, { "@type": "ScholarlyArticle", "name": "Influence of the leukoreduction moment of blood components on the clinical outcomes of transfused patients in the emergency department.", "datePublished": "2024-08-26", "url": "https://questionsmedicales.fr/article/39194129", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/0034-7167-2023-0293" } }, { "@type": "ScholarlyArticle", "name": "Hypocalcemia in Trauma is Determined by the Number of Units Transfused, Not Whole Blood Versus Component Therapy.", "datePublished": "2023-05-04", "url": "https://questionsmedicales.fr/article/37148855", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jss.2023.03.043" } }, { "@type": "ScholarlyArticle", "name": "Parents' understanding and experiences of blood component transfusion in the neonatal intensive care unit: A qualitative study.", "datePublished": "2023-08-24", "url": "https://questionsmedicales.fr/article/37615240", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/apa.16952" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérobicycliques", "item": "https://questionsmedicales.fr/mesh/D006574" }, { "@type": "ListItem", "position": 5, "name": "Purines", "item": "https://questionsmedicales.fr/mesh/D011687" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Purines - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Purines", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-04-30", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Purines", "description": "Comment diagnostiquer une hyperuricémie ?\nQuels tests pour la goutte ?\nQuels symptômes indiquent une crise de goutte ?\nComment évaluer une maladie liée aux purines ?\nQuel rôle des purines dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D011687?mesh_terms=Blood+Component+Transfusion#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Purines", "description": "Quels sont les symptômes de l'hyperuricémie ?\nQuels signes de goutte aiguë ?\nComment se manifeste une crise de goutte ?\nQuels symptômes des troubles des purines ?\nQuels symptômes d'une maladie de Wilson ?", "url": "https://questionsmedicales.fr/mesh/D011687?mesh_terms=Blood+Component+Transfusion#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Purines", "description": "Comment prévenir l'hyperuricémie ?\nQuelles habitudes pour éviter la goutte ?\nComment réduire le risque de calculs rénaux ?\nQuels conseils diététiques pour les purines ?\nComment surveiller les niveaux d'acide urique ?", "url": "https://questionsmedicales.fr/mesh/D011687?mesh_terms=Blood+Component+Transfusion#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Purines", "description": "Comment traiter l'hyperuricémie ?\nQuel traitement pour la goutte ?\nComment prévenir les crises de goutte ?\nQuels médicaments pour les troubles des purines ?\nComment gérer les calculs rénaux liés aux purines ?", "url": "https://questionsmedicales.fr/mesh/D011687?mesh_terms=Blood+Component+Transfusion#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Purines", "description": "Quelles complications de la goutte ?\nQuels risques liés à l'hyperuricémie ?\nComment l'hyperuricémie affecte-t-elle les reins ?\nQuelles complications des troubles des purines ?\nQuels effets à long terme de la goutte ?", "url": "https://questionsmedicales.fr/mesh/D011687?mesh_terms=Blood+Component+Transfusion#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Purines", "description": "Quels facteurs de risque pour l'hyperuricémie ?\nQui est à risque de goutte ?\nQuels médicaments augmentent le risque d'hyperuricémie ?\nQuel rôle de l'alimentation dans les purines ?\nComment l'âge influence-t-il l'hyperuricémie ?", "url": "https://questionsmedicales.fr/mesh/D011687?mesh_terms=Blood+Component+Transfusion#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une hyperuricémie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un test sanguin mesure le taux d'acide urique pour diagnostiquer l'hyperuricémie." } }, { "@type": "Question", "name": "Quels tests pour la goutte ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'analyse du liquide synovial et des tests sanguins pour l'acide urique sont utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent une crise de goutte ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Douleur intense, rougeur et gonflement d'une articulation, souvent le gros orteil." } }, { "@type": "Question", "name": "Comment évaluer une maladie liée aux purines ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des analyses biochimiques peuvent être nécessaires." } }, { "@type": "Question", "name": "Quel rôle des purines dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les niveaux de purines peuvent indiquer des troubles métaboliques ou des maladies rénales." } }, { "@type": "Question", "name": "Quels sont les symptômes de l'hyperuricémie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Souvent asymptomatique, mais peut causer des douleurs articulaires et des calculs rénaux." } }, { "@type": "Question", "name": "Quels signes de goutte aiguë ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Douleur intense, rougeur, chaleur et gonflement d'une articulation, souvent nocturne." } }, { "@type": "Question", "name": "Comment se manifeste une crise de goutte ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Une douleur soudaine et sévère dans une articulation, souvent accompagnée d'inflammation." } }, { "@type": "Question", "name": "Quels symptômes des troubles des purines ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, douleurs articulaires, et parfois des problèmes rénaux ou hépatiques." } }, { "@type": "Question", "name": "Quels symptômes d'une maladie de Wilson ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Accumulation de cuivre, troubles neurologiques, et symptômes hépatiques." } }, { "@type": "Question", "name": "Comment prévenir l'hyperuricémie ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Adopter un régime pauvre en purines et éviter l'alcool et les boissons sucrées." } }, { "@type": "Question", "name": "Quelles habitudes pour éviter la goutte ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir un poids santé, rester hydraté et limiter les aliments riches en purines." } }, { "@type": "Question", "name": "Comment réduire le risque de calculs rénaux ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Boire beaucoup d'eau et éviter les aliments riches en oxalates et purines." } }, { "@type": "Question", "name": "Quels conseils diététiques pour les purines ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Limiter les viandes rouges, les fruits de mer et les boissons alcoolisées." } }, { "@type": "Question", "name": "Comment surveiller les niveaux d'acide urique ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins réguliers pour surveiller les niveaux d'acide urique et ajuster le régime." } }, { "@type": "Question", "name": "Comment traiter l'hyperuricémie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme les inhibiteurs de la xanthine oxydase et des changements alimentaires." } }, { "@type": "Question", "name": "Quel traitement pour la goutte ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Anti-inflammatoires non stéroïdiens (AINS) et colchicine pour soulager la douleur." } }, { "@type": "Question", "name": "Comment prévenir les crises de goutte ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les aliments riches en purines et maintenir une hydratation adéquate." } }, { "@type": "Question", "name": "Quels médicaments pour les troubles des purines ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments spécifiques selon le trouble, comme les uricosuriques pour l'hyperuricémie." } }, { "@type": "Question", "name": "Comment gérer les calculs rénaux liés aux purines ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Hydratation, modifications alimentaires et parfois intervention chirurgicale." } }, { "@type": "Question", "name": "Quelles complications de la goutte ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Arthrite chronique, dépôts de tophus et risque accru de maladies cardiovasculaires." } }, { "@type": "Question", "name": "Quels risques liés à l'hyperuricémie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Peut entraîner des calculs rénaux, des maladies rénales et des problèmes cardiovasculaires." } }, { "@type": "Question", "name": "Comment l'hyperuricémie affecte-t-elle les reins ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Peut provoquer une néphropathie urique, entraînant des lésions rénales." } }, { "@type": "Question", "name": "Quelles complications des troubles des purines ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Peuvent inclure des problèmes hépatiques, neurologiques et des troubles métaboliques." } }, { "@type": "Question", "name": "Quels effets à long terme de la goutte ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Peut entraîner des dommages articulaires permanents et des complications systémiques." } }, { "@type": "Question", "name": "Quels facteurs de risque pour l'hyperuricémie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Obésité, consommation excessive d'alcool, régime riche en purines et antécédents familiaux." } }, { "@type": "Question", "name": "Qui est à risque de goutte ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les hommes, les personnes obèses et celles ayant des antécédents familiaux de goutte." } }, { "@type": "Question", "name": "Quels médicaments augmentent le risque d'hyperuricémie ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Diurétiques, aspirine à faible dose et certains médicaments immunosuppresseurs." } }, { "@type": "Question", "name": "Quel rôle de l'alimentation dans les purines ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en viandes rouges, fruits de mer et boissons sucrées augmente le risque." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il l'hyperuricémie ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Le risque d'hyperuricémie augmente avec l'âge, surtout chez les hommes après 40 ans." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 18/04/2025

Contenu vérifié selon les dernières recommandations médicales

Sous-catégories

31 au total
└─

Adénine

Adenine D000225 - D03.633.100.759.138
└─

Allopurinol

Allopurinol D000493 - D03.633.100.759.160
└─

Mercaptopurine

Mercaptopurine D015122 - D03.633.100.759.570
└─

Purinones

Purinones D011688 - D03.633.100.759.758
└─

Roscovitine

Roscovitine D000077546 - D03.633.100.759.776
└─

Citrate de sildénafil

Sildenafil Citrate D000068677 - D03.633.100.759.824
└─

Tioguanine

Thioguanine D013866 - D03.633.100.759.854
└─└─

Amino-2 purine

2-Aminopurine D015075 - D03.633.100.759.138.050
└─└─

Cytokinine

Cytokinins D003583 - D03.633.100.759.138.525
└─└─

Famciclovir

Famciclovir D000077595 - D03.633.100.759.138.703
└─└─

Ténofovir

Tenofovir D000068698 - D03.633.100.759.138.881
└─└─

Hypoxanthines

Hypoxanthines D007042 - D03.633.100.759.758.399
└─└─

Xanthines

Xanthines D014970 - D03.633.100.759.758.824
└─└─└─

Kinétine

Kinetin D007701 - D03.633.100.759.138.525.400
└─└─└─

Zéatine

Zeatin D015026 - D03.633.100.759.138.525.700
└─└─└─

Guanine

Guanine D006147 - D03.633.100.759.758.399.454
└─└─└─

Hypoxanthine

Hypoxanthine D019271 - D03.633.100.759.758.399.475
└─└─└─

Caféine

Caffeine D002110 - D03.633.100.759.758.824.175
└─└─└─

Théobromine

Theobromine D013805 - D03.633.100.759.758.824.651
└─└─└─

Théophylline

Theophylline D013806 - D03.633.100.759.758.824.751
└─└─└─

Acide urique

Uric Acid D014527 - D03.633.100.759.758.824.877
└─└─└─

Xanthine

Xanthine D019820 - D03.633.100.759.758.824.938
└─└─└─└─

Aciclovir

Acyclovir D000212 - D03.633.100.759.758.399.454.250
└─└─└─└─

8-Azaguanine

Azaguanine D001375 - D03.633.100.759.758.399.454.300
└─└─└─└─

Pentoxifylline

Pentoxifylline D010431 - D03.633.100.759.758.824.651.700
└─└─└─└─

Diphylline

Dyphylline D004400 - D03.633.100.759.758.824.751.250
└─└─└─└─

Xanthine(isobutyl-3 methyl-1)

1-Methyl-3-isobutylxanthine D015056 - D03.633.100.759.758.824.751.500
└─└─└─└─

Nicotinate de xanthinol

Xanthinol Niacinate D014971 - D03.633.100.759.758.824.751.950
└─└─└─└─└─

Ganciclovir

Ganciclovir D015774 - D03.633.100.759.758.399.454.250.300
└─└─└─└─└─

Valaciclovir

Valacyclovir D000077483 - D03.633.100.759.758.399.454.250.650
└─└─└─└─└─└─

Valganciclovir

Valganciclovir D000077562 - D03.633.100.759.758.399.454.250.300.500

Auteurs principaux

Bertrand Daignan-Fornier

3 publications dans cette catégorie

Affiliations :
  • Institut de Biochimie et Génétique Cellulaires, CNRS, UMR 5095, Université de Bordeaux, F-33000 Bordeaux, France.

Benoît Pinson

3 publications dans cette catégorie

Affiliations :
  • Institut de Biochimie et Génétique Cellulaires, CNRS, UMR 5095, Université de Bordeaux, F-33000 Bordeaux, France.

M Zaeem Cader

2 publications dans cette catégorie

Affiliations :
  • Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.

Rodrigo Pereira de Almeida Rodrigues

2 publications dans cette catégorie

Affiliations :
  • Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.

James A West

2 publications dans cette catégorie

Affiliations :
  • Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK; Department of Biochemistry and Cambridge Systems Biology Centre, University of Cambridge, Cambridge CB2 1GA, UK.

Gavin W Sewell

2 publications dans cette catégorie

Affiliations :
  • Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.

Muhammad N Md-Ibrahim

2 publications dans cette catégorie

Affiliations :
  • Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.

Lukas W Unger

2 publications dans cette catégorie

Affiliations :
  • Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.

Ana Belén Iglesias-Romero

2 publications dans cette catégorie

Affiliations :
  • Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.

Katharina Ramshorn

2 publications dans cette catégorie

Affiliations :
  • Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.

Lea-Maxie Haag

2 publications dans cette catégorie

Affiliations :
  • Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.

Svetlana Saveljeva

2 publications dans cette catégorie

Affiliations :
  • Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.

Nicole C Kaneider

2 publications dans cette catégorie

Affiliations :
  • Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.

James C Lee

2 publications dans cette catégorie

Affiliations :
  • Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.

Trevor D Lawley

2 publications dans cette catégorie

Affiliations :
  • Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.

Allan Bradley

2 publications dans cette catégorie

Affiliations :
  • Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.

Gordon Dougan

2 publications dans cette catégorie

Affiliations :
  • Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Division of Infectious Diseases, Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.

Arthur Kaser

2 publications dans cette catégorie

Affiliations :
  • Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK; Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK. Electronic address: ak729@cam.ac.uk.

Wei Jiang

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Functional Molecular Engineering of Guangdong Province, School of Chemistry and Chemical Engineering , South China University of Technology , Guangzhou 510641 , P. R. China.

Juanping Zhuge

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Functional Molecular Engineering of Guangdong Province, School of Chemistry and Chemical Engineering , South China University of Technology , Guangzhou 510641 , P. R. China.

Sources (10000 au total)

Balanced blood component resuscitation in trauma: Does it matter equally at different transfusion volumes?

It remains unclear whether the association between balanced blood component transfusion and lower mortality is generalizable to trauma patients receiving varying transfusion volumes. We sought to stud... Adult patients in the 2013 to 2018 American College of Surgeons Trauma Quality Improvement Program database receiving ≥6 red blood cell, ≥1 platelet, and ≥1 fresh frozen plasma within 4 hours were inc... A total of 14,549 patients were included. In patients receiving 6 to 10 units of red blood cells, red blood cell:platelet ratios were not associated with 4-hour mortality, and only red blood cell:fres... The association between balanced blood component transfusion and 4-hour mortality is not homogenous in trauma patients requiring different transfusion volumes and is specifically less evident in patie...

Influence of the leukoreduction moment of blood components on the clinical outcomes of transfused patients in the emergency department.

to investigate the influence of the leukoreduction moment (preor post-storage) of blood components on the clinical outcomes of patients transfused in the emergency department.... retrospective cohort study of patients aged 18 years or older who received preor post-storage leukoreduced red blood cell or platelet concentrate in the emergency department and remained in the instit... in a sample of 373 patients (63.27% male, mean age 54.83) and 643 transfusions (69.98% red blood cell), it was identified that the leukoreduction moment influenced the length of hospital stay (p<0.009... patients who received pre-storage leukoreduced blood components in the emergency department had a shorter length of hospital stay....

Hypocalcemia in Trauma is Determined by the Number of Units Transfused, Not Whole Blood Versus Component Therapy.

Blood component resuscitation is associated with hypocalcemia (HC) (iCal <0.9 mmol/L) that contributes to coagulopathy and death in trauma patients. It is unknown whether or not whole blood (WB) resus... This is a retrospective review of all adult trauma patients who received WB from July 2018 to December 2020. Variables included transfusions, ionized calcium levels, and calcium replacement. Patients ... Two hundred twenty-three patients received WB and met the inclusion criteria. 107 (48%) received WB only. HC occurred in 13% of patients who received more than one WB unit compared to 29% of WB and ot... HC and failure to correct HC are significant risk factors for mortality in trauma. Resuscitations with WB only and WB in combination with other blood components are associated with HC especially when ...

Parents' understanding and experiences of blood component transfusion in the neonatal intensive care unit: A qualitative study.

Blood component transfusion is a common intervention in the neonatal intensive care unit (NICU). Parents consent on their babies' behalf. This study aimed to explore parents' understandings and experi... A "low inference" qualitative descriptive semi-structured interview approach was utilised. Grounded theory was employed. Parents described their memories of babies' transfusions, their responses to th... A purposive sample of 17 parents whose babies required blood transfusion in the NICU participated. Parents talked about their initial fears of transfusion, later replaced by confidence in the process ... Parents in our study trust information from the healthcare professionals caring for their baby and would like more specific information about how blood transfusion will impact their baby, in a variety...

Blood component-associated acute transfusion reactions in pediatric patients: experience of a tertiary care hospital.

The transfusion of blood products is a life-saving clinical practice in patients with bleeding, hemoglobinopathy, and cancer. It was aimed herein to analyze the frequency and types of blood component-... This retrospective study was conducted at a tertiary care academic pediatric hospital.... During the study period, 30,811 transfusions were administered to 25,448 patients. There were 103 ATRs detected in 81 patients (0.33%; 3.34 reactions per 1000 transfusions, mean age 8.3 ± 5.98 years, ... Within our hospital, pediatric hematology-oncology wards and the stem cell transplantation unit had the most frequent ATR reports; therefore, when transfusions are carried out, increased attention sho...

Transfusion-related cost comparison of trauma patients receiving whole blood versus component therapy.

With the emergence of whole blood (WB) in trauma resuscitation, cost-related comparisons are of significant importance to providers, blood banks, and hospital systems throughout the country. The objec... A retrospective review of adult and pediatric trauma patients who received either LTO+WB or CT from time of injury to within 4 hours of arrival was performed. Annual mean cost per unit of blood produc... Prehospital LTO+WB transfusion began at this institution in January 2018. After the initiation of the WB transfusion, the mean annual cost decreased 17.3% for all blood products, and the average net d... With increased use of LTO+WB for resuscitation, cost comparison is of significant importance to all stakeholders. Low titer O+ WB was associated with reduced cost in severely injured patients. Ongoing... Therapeutic/Care Management; Level IV....

The abrogated role of premedication in the prevention of transfusion-associated adverse reactions in outpatients receiving leukocyte-reduced blood components.

Although it remains controversial, premedication before transfusion is a common clinical practice to prevent transfusion-associated adverse reactions (TAARs) in Taiwan. Thus, we aimed to investigate w... Clinical data from outpatients receiving transfusion therapy, including predisposing diseases, histories of transfusion and TAARs, premedication and the occurrence of TAARs in the period April 2017 to... A total of 5018 blood units were transfused to 803 outpatients, with 2493 transfusion events reported in the study interval. The most frequently transfused component was leukocyte-reduced packed red c... Decreased premedication was not associated with increased incidence of TAARs in outpatients; these findings provide important evidence to support the need to revise clinical practices in the era of le...

How to improve issuing, transfusion and follow-up of blood components in Southern and Eastern Mediterranean countries? A benchmark assessment.

To determine the existence of guidelines regarding the appropriate clinical use of blood and blood components, transfusion requests, and blood issuing/reception documents and procedures. The different...

Outcomes of Transfusion With Whole Blood, Component Therapy, or Both in Adult Civilian Trauma Patients: A Systematic Review and Meta-Analysis.

This systematic review and meta-analysis was conducted to compare outcomes, including transfusion volume, complications, intensive care unit length of stay, and mortality for adult civilian trauma pat... A systematic review and meta-analysis were conducted using studies that evaluated outcomes of transfusion of WB, COMP, or WB + COMP for adult civilian trauma patients. A search of PubMed, Embase, and ... This study identified an increased risk of 24-h mortality with COMP versus WB + COMP (relative risk: 1.40 [1.10, 1.78]) and increased transfusion volumes of red blood cells with COMP versus WB at 6 an... Transfusion with WB + COMP is associated with lower 24-h mortality versus COMP and transfusion with WB is associated with a lower volume of red blood cells transfused at both 6 and 24 h. Based on thes...